1 |
<html> |
2 |
<head> |
3 |
<!--Section Begins--> |
4 |
</head> |
5 |
<body> |
6 |
<br> |
7 |
<br> |
8 |
|
9 |
<div align="Justify"> |
10 |
<p style="text-align: justify; "> </p> |
11 |
</div> |
12 |
|
13 |
<div align="Justify"> |
14 |
<p style="text-align: justify; "> VETALGIN </p> |
15 |
</div> |
16 |
|
17 |
<div align="Justify"> |
18 |
<p style="text-align: justify; "> injekcije </p> |
19 |
</div> |
20 |
|
21 |
<div align="Justify"> |
22 |
<p style="text-align: justify; "> </p> |
23 |
</div> |
24 |
|
25 |
<div align="Justify"> |
26 |
<p style="text-align: justify; "> Sestava </p> |
27 |
</div> |
28 |
|
29 |
<div align="Justify"> |
30 |
<p style="text-align: justify; "> 1 ml raztopine vsebuje: </p> |
31 |
</div> |
32 |
|
33 |
<div align="Justify"> |
34 |
<p style="text-align: justify; "> 500 mg metamizolovega natrija. </p> |
35 |
</div> |
36 |
|
37 |
<div align="Justify"> |
38 |
<p style="text-align: justify; "> </p> |
39 |
</div> |
40 |
|
41 |
<div align="Justify"> |
42 |
<p style="text-align: justify; "> Delovanje </p> |
43 |
</div> |
44 |
|
45 |
<div align="Justify"> |
46 |
<p style="text-align: justify; "> Vetalginovo izrazito spazmolitièno |
47 |
delovanje temelji na soèasnem pomirjanju centra za boleèino |
48 |
in vegetativnih centrov. Obenem pride tudi do razširitve perifernih krvnih |
49 |
¾il in s tem do boljše oskrbe preèno progastega mišièja |
50 |
s krvjo. Zelo dobro analgetièno delovanje pripravka je posledica uèinka |
51 |
na center za boleèino. Antipiretièno delovanje Vetalgina je |
52 |
enako aminopirinovemu. Po parenteralnem vnosu nastopi ta uèinek poèasi, |
53 |
a traja dlje èasa. Zdravilo nima nikakršnih neza¾elenih stranskih |
54 |
uèinkov. </p> |
55 |
</div> |
56 |
|
57 |
<div align="Justify"> |
58 |
<p style="text-align: justify; "> </p> |
59 |
</div> |
60 |
|
61 |
<div align="Justify"> |
62 |
<p style="text-align: justify; "> Indikacije </p> |
63 |
</div> |
64 |
|
65 |
<div align="Justify"> |
66 |
<p style="text-align: justify; "> Kolike pri konjih zaradi krèevite |
67 |
peristaltike pri kataralnih enteralgijah; èrevesni meteorizem; tonièni |
68 |
èrevesni krè pri zapori tankega èrevesa; zapore po¾iralnika |
69 |
pri konjih, govedu in prašièih; lumbago pri konjih; pomo¾no |
70 |
zdravljenje tetanusa; akutni vnetni procesi lokomotornega aparata; pareza |
71 |
zadnjega dela telesa pri psih; premoène in prezgodnje boleèine |
72 |
med kotenjem; bolezni, pri katerih se pojavijo vroèica, strah in nemir |
73 |
zaradi boleèine pred zdravljenjem in pregledom ¾ivali. </p> |
74 |
</div> |
75 |
|
76 |
<div align="Justify"> |
77 |
<p style="text-align: justify; "> </p> |
78 |
</div> |
79 |
|
80 |
<div align="Justify"> |
81 |
<p style="text-align: justify; "> Kontraindikacije </p> |
82 |
</div> |
83 |
|
84 |
<div align="Justify"> |
85 |
<p style="text-align: justify; "> Niso znane. </p> |
86 |
</div> |
87 |
|
88 |
<div align="Justify"> |
89 |
<p style="text-align: justify; "> </p> |
90 |
</div> |
91 |
|
92 |
<div align="Justify"> |
93 |
<p style="text-align: justify; "> Naèin uporabe in odmerki </p> |
94 |
</div> |
95 |
|
96 |
<div align="Justify"> |
97 |
<p style="text-align: justify; "> Vetalgin dajemo intravensko ali intramuskularno. |
98 |
Proti moènim boleèinam ga dajemo intravensko. Drugaèe |
99 |
je priporoèljivo kombinirano intravensko in intramuskularno dajanje. |
100 |
</p> |
101 |
</div> |
102 |
|
103 |
<div align="Justify"> |
104 |
<p style="text-align: justify; "> </p> |
105 |
</div> |
106 |
|
107 |
<div align="Justify"> |
108 |
<p style="text-align: justify; "> Konj, govedo 20 do 60 ml </p> |
109 |
</div> |
110 |
|
111 |
<div align="Justify"> |
112 |
<p style="text-align: justify; "> ®rebe, tele 5 do 15 ml </p> |
113 |
</div> |
114 |
|
115 |
<div align="Justify"> |
116 |
<p style="text-align: justify; "> Ovca, koza 2 do 3 ml </p> |
117 |
</div> |
118 |
|
119 |
<div align="Justify"> |
120 |
<p style="text-align: justify; "> Prašiè 3 do 15 ml </p> |
121 |
</div> |
122 |
|
123 |
<div align="Justify"> |
124 |
<p style="text-align: justify; "> Pes 1 do 5 ml </p> |
125 |
</div> |
126 |
|
127 |
<div align="Justify"> |
128 |
<p style="text-align: justify; "> Konjem dajemo pripravek v glavnem intravensko. |
129 |
</p> |
130 |
</div> |
131 |
|
132 |
<div align="Justify"> |
133 |
<p style="text-align: justify; "> </p> |
134 |
</div> |
135 |
|
136 |
<div align="Justify"> |
137 |
<p style="text-align: justify; "> Stranski pojavi </p> |
138 |
</div> |
139 |
|
140 |
<div align="Justify"> |
141 |
<p style="text-align: justify; "> Niso znani. </p> |
142 |
</div> |
143 |
|
144 |
<div align="Justify"> |
145 |
<p style="text-align: justify; "> </p> |
146 |
</div> |
147 |
|
148 |
<div align="Justify"> |
149 |
<p style="text-align: justify; "> Stranski pojavi in previdnostni ukrepi |
150 |
</p> |
151 |
</div> |
152 |
|
153 |
<div align="Justify"> |
154 |
<p style="text-align: justify; "> Subkutana uporaba Vetalgina ni priporoèljiva |
155 |
zaradi moènega lokalnega dra¾enja tkiva. </p> |
156 |
</div> |
157 |
|
158 |
<div align="Justify"> |
159 |
<p style="text-align: justify; "> </p> |
160 |
</div> |
161 |
|
162 |
<div align="Justify"> |
163 |
<p style="text-align: justify; "> Karenca </p> |
164 |
</div> |
165 |
|
166 |
<div align="Justify"> |
167 |
<p style="text-align: justify; "> Meso in organi niso primerni za prehrano |
168 |
ljudi med dajanjem in 12 dni po zadnjem vnosu zdravila. </p> |
169 |
</div> |
170 |
|
171 |
<div align="Justify"> |
172 |
<p style="text-align: justify; "> Mleko ni primerno za prehrano ljudi med |
173 |
dajanjem in 4 dni po zadnjem vnosu zdravila. </p> |
174 |
</div> |
175 |
|
176 |
<div align="Justify"> |
177 |
<p style="text-align: justify; "> </p> |
178 |
</div> |
179 |
|
180 |
<div align="Justify"> |
181 |
<p style="text-align: justify; "> Naèin shranjevanja </p> |
182 |
</div> |
183 |
|
184 |
<div align="Justify"> |
185 |
<p style="text-align: justify; "> Shranite zašèiteno pred svetlobo, |
186 |
pri temperaturi do 25 °C in nedosegljivo otrokom. </p> |
187 |
</div> |
188 |
|
189 |
<div align="Justify"> |
190 |
<p style="text-align: justify; "> <b></b> </p> |
191 |
</div> |
192 |
|
193 |
<div align="Justify"> |
194 |
<p style="text-align: justify; "> Postopek s prazno ovojnino </p> |
195 |
</div> |
196 |
|
197 |
<div align="Justify"> |
198 |
<p style="text-align: justify; "> Prazno ovojnino ali ostanke zdravil je |
199 |
treba obravnavati kot nevarne odpadke. </p> |
200 |
</div> |
201 |
|
202 |
<div align="Justify"> |
203 |
<p style="text-align: justify; "> </p> |
204 |
</div> |
205 |
|
206 |
<div align="Justify"> |
207 |
<p style="text-align: justify; "> Naèin izdajanja </p> |
208 |
</div> |
209 |
|
210 |
<div align="Justify"> |
211 |
<p style="text-align: justify; "> Na recept. </p> |
212 |
</div> |
213 |
|
214 |
<div align="Justify"> |
215 |
<p style="text-align: justify; "> </p> |
216 |
</div> |
217 |
|
218 |
<div align="Justify"> |
219 |
<p style="text-align: justify; "> Rok uporabnosti </p> |
220 |
</div> |
221 |
|
222 |
<div align="Justify"> |
223 |
<p style="text-align: justify; "> Oznaèen je na ovojnini (3 leta). |
224 |
</p> |
225 |
</div> |
226 |
|
227 |
<div align="Justify"> |
228 |
<p style="text-align: justify; "> </p> |
229 |
</div> |
230 |
|
231 |
<div align="Justify"> |
232 |
<p style="text-align: justify; "> <b>EKZ 1 11 6</b> </p> |
233 |
</div> |
234 |
|
235 |
<div align="Justify"> |
236 |
<p style="text-align: justify; "> </p> |
237 |
</div> |
238 |
|
239 |
<div align="Justify"> |
240 |
<p style="text-align: justify; "> <b>Številka in datum odloèbe</b> |
241 |
</p> |
242 |
</div> |
243 |
|
244 |
<div align="Justify"> |
245 |
<p style="text-align: justify; "> 323-03-8/00-21, 02.06.2000 </p> |
246 |
</div> |
247 |
|
248 |
<div align="Justify"> |
249 |
<p style="text-align: justify; "> </p> |
250 |
</div> |
251 |
|
252 |
<div align="Justify"> |
253 |
<p style="text-align: justify; "> Oprema </p> |
254 |
</div> |
255 |
|
256 |
<div align="Justify"> |
257 |
<p style="text-align: justify; "> Steklenièke s 50 ml </p> |
258 |
</div> |
259 |
|
260 |
<div align="Justify"> |
261 |
<p style="text-align: justify; "> </p> |
262 |
</div> |
263 |
|
264 |
<div align="Justify"> |
265 |
<p style="text-align: justify; "> Proizvajalec </p> |
266 |
</div> |
267 |
|
268 |
<div align="Justify"> |
269 |
<p style="text-align: justify; "> Pliva, d. d., Zagreb, Hrvaška </p> |
270 |
</div> |
271 |
|
272 |
<div align="Justify"> |
273 |
<p style="text-align: justify; "> </p> |
274 |
</div> |
275 |
|
276 |
<div align="Justify"> |
277 |
<p style="text-align: justify; "> Zastopnik </p> |
278 |
</div> |
279 |
|
280 |
<div align="Justify"> |
281 |
<p style="text-align: justify; "> Pliva Ljubljana, d. o. o., Slovenija </p> |
282 |
</div> |
283 |
|
284 |
<div align="Justify"> |
285 |
<p style="text-align: justify; "> </p> |
286 |
</div> |
287 |
|
288 |
<div align="Justify"> |
289 |
<p style="text-align: justify; "> Revidirano na seji 1/2000 Komisije za |
290 |
registracijo zdravil za uporabo v veterinarski medicini dne 21.04.2000.. |
291 |
</p> |
292 |
</div> |
293 |
<!--Section Ends--> |
294 |
</body> |
295 |
</html> |